ADAP Waiting Lists

The Aids Drug Assistance Programs through out the country have been running in to financial difficulties due to an insufficient federal appropriation compared to the rate ADAP utilization has increased, the current recession generated state revenue and budget crisis, and the loss of jobs and health insurance across the nation. ADAPs have been unable to supply medications to everyone who is eligible for them, and as a result waiting lists and cost containment measures have been established throughout the country. Currently, 4,274 individuals in twelve states have been placed on an ADAP waiting list, and it is unknown if they are receiving the life-saving drugs they desperately need. In addition, five states have disenrolled individuals from their ADAPs and more states are expected to disenroll or place individuals on ADAP waiting lists. Please see the below resources for additional information.

ADAPs are discretionarily funded programs and are a payer of last resort. As such, individuals who rely on ADAP struggle to obtain medications from other sources when waiting lists and cost containment measures are instituted by state governments because of a lack of funding. Since 2004, federal funding for ADAP has not kept pace with the 40,000 new enrollees (approximately a 33% increase). Various efforts have been instituted in that time to help alleviate some of the burden on ADAP, but they have been insufficient to account for the lack of federal funding. As a result, states continue to face a greater and greater ADAP burden. In 2000 about 70% of ADAP expenditures were funded by the federal government. That share has decreased to less than 50% in 2010. Between 2000 and 2008, states increased the amount dedicated to ADAP by 150%, while the federal share has only increased 47% in the same amount of time.

Current Waiting Lists and Cost-Containment Measures

December 2, 2011 Waiting Lists

Alabama: 85 individuals
Georgia: 1,520 individuals
Louisiana: 515 individuals
Nebraska: 9 individuals
Ohio: 0 individuals
Utah: 23 individuals

Florida: 806 individuals
Idaho: 5 individuals
Montana: 9 individuals
North Carolina: 106 individuals
South Carolina: 92 individuals
Virginia: 1,104 individuals

Cost-Containment Measures

Alabama: Reduced formulary
Arizona: Reduced formulary
Colorado: Reduced formulary
Georgia: Reduced formulary, implemented medical criteria
Idaho: Capped enrollment
Kentucky: Reduced formulary
North Dakota: Capped enrollment, reduced eligibility (300% FPL)
Puerto Rico: Reduced formulary
Utah: Reduced formulary, reduced eligibility (250% FPL), disenrolled 89 individuals
Washington: Reduced formulary, instituted client cost sharing

Arkansas: Reduced formulary, lowered eligibility (200% FPL), disenrolled 99 individuals
Florida: Reduced formulary, lowered eligibility (300% FPL)
Illinois: Reduced formulary, instituted monthly expenditure cap, lowered eligibility (300% FPL)
Louisiana: Laboratory funding reductions
North Carolina: Reduced formulary
Ohio: Reduced formulary, reduced eligibility (300% FPL), disenrolled 257 individuals
South Carolina: Reduced eligibility (300% FPL)
Virginia: Reduced formulary, disenrolled 760 individuals
Wyoming: Reduced formulary, instituted client cost sharing

Illinois Announces Plans to Decrease Access to HIV Medications

South Carolina Wait List Letter to Provider April 27, 2010

ADAP Crisis Update October 2010

Colorado Decreased Formulary Letter to Provider January 27, 2010